WallStreetZenWallStreetZen

NASDAQ: PRLD
Prelude Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Prelude Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PRLD annual revenue was $0.0, with N/A growth year-over-year.

PRLD revenue history

Current Revenue
$0.0
Current Earnings
-$127.2M
Current Profit Margin
0%

Be the first to know when PRLD announces revenue.

PRLD Revenue History By Year

PRLD Yearly RevenuePRLD RevenuePRLD ChangePRLD Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Prelude Therapeutics Revenue FAQ

What was PRLD's revenue last quarter?

On Invalid Date, Prelude Therapeutics (NASDAQ: PRLD) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Prelude Therapeutics's revenue was $0.00.

What was Prelude Therapeutics's revenue in 2024?

Prelude Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Prelude Therapeutics make in a day?

Based on Prelude Therapeutics annual revenue for the past five years, PRLD makes an average of $0.00 per day.

What was Prelude Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Prelude Therapeutics's revenue has grown null year over year. Prelude Therapeutics's revenue in the past year totaled $0.00.

How much does Prelude Therapeutics make in a year?

Prelude Therapeutics's revenue by year for the past five years is:
  • Prelude Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Prelude Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Prelude Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Prelude Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Prelude Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.